96. Crohn disease Clinical trials / Disease details

Clinical trials : 2,400 / Drugs : 1,391 - (DrugBank : 267) / Drug target genes : 170 - Drug target pathways : 215

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00989573 (ClinicalTrials.gov)	October 2009	2/10/2009	A Dose-finding and Confirmatory Trial of OPC-6535 in Patients With Active Crohn's Disease	A Multinational, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-finding and Confirmatory Trial of OPC-6535 in Patients With Active Crohn's Disease	Crohn's Disease	Drug: Placebo;Drug: OPC-6535	Otsuka Pharmaceutical Co., Ltd.	NULL	Completed	18 Years	64 Years	Both	191	Phase 2/Phase 3	Japan;Korea, Republic of
2	NCT00317369 (ClinicalTrials.gov)	May 2006	21/4/2006	A Dose-Finding Study of OPC-6535 in Patients With Active Crohn's Disease	A Dose-Finding Study of OPC-6535 in Patients With Active Crohn's Disease	Crohn Disease	Drug: OPC-6535(Tetomilast)	Otsuka Pharmaceutical Co., Ltd.	NULL	Terminated	16 Years	65 Years	Both	60	Phase 2	Japan